(Q26798113)

Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines

inferred from page(s)

published in

Neuropharmacology

0 references

volume

100

0 references

page(s)

27-39

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The Ca2+ and Rho GTPase signaling pathways underlying activity-dependent actin remodeling at dendritic spines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The emerging role of SHANK genes in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Rho small G-protein-dependent binding of mDia to an Src homology 3 domain-containing IRSp53/BAIAP2

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Distinctive tissue distribution and phosphorylation of IRSp53 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

CIPP, a novel multivalent PDZ domain protein, selectively interacts with Kir4.0 family members, NMDA receptor subunits, neurexins, and neuroligins

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of the actin cytoskeleton in dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Atrophins' emerging roles in development and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Genomic structure and alternative splicing of the insulin receptor tyrosine kinase substrate of 53-kDa protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Calcium-induced actin depolymerization reduces NMDA channel activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Independent mechanisms for long-term depression of AMPA and NMDA responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The postsynaptic density

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dentatorubral-pallidoluysian atrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SHANK1 Deletions in Males with Autism Spectrum Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SH2B1 increases the numbers of IRSp53-induced filopodia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The postsynaptic density protein, IQ-ArfGEF/BRAG1, can interact with IRSp53 through its proline-rich sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Calcium regulation of actin dynamics in dendritic spines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Molecular mechanisms of dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Ena/VASP: proteins at the tip of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

A synaptic trek to autism

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Structural plasticity of dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

NMDA receptor dysfunction in autism spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dip1 defines a class of Arp2/3 complex activators that function without preformed actin filaments

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Familial KANK1 deletion that does not follow expected imprinting pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Association study of six candidate genes asymmetrically expressed in the two cerebral hemispheres suggests the involvement of BAIAP2 in autism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Are NMDA receptor antagonists beneficial in the treatment of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The state of the actin cytoskeleton determines its association with gephyrin: role of ena/VASP family members

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Glutamate receptor dynamics and protein interaction: lessons from the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Glutamate receptor dynamics in dendritic microdomains

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of NMDA receptors by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Control of synapse development and plasticity by Rho GTPase regulatory proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

I-BAR domains, IRSp53 and filopodium formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Subcellular membrane curvature mediated by the BAR domain superfamily proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Neuronal polarization and the cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Convergent CaMK and RacGEF signals control dendritic structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SPIN90-IRSp53 complex participates in Rac-induced membrane ruffling

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

WAVE2 serves a functional partner of IRSp53 by regulating its interaction with Rac

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

MALS is a binding partner of IRSp53 at cell-cell contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of dendritic spine morphology and synaptic function by Shank and Homer

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Sustained activation of N-WASP through phosphorylation is essential for neurite extension

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Model of autism: increased ratio of excitation/inhibition in key neural systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Competitive binding of alpha-actinin and calmodulin to the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

CDC42 switches IRSp53 from inhibition of actin growth to elongation by clustering of VASP

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Glycine binding primes NMDA receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Phosphoinositides in cell regulation and membrane dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Neocortical excitation/inhibition balance in information processing and social dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

De novo mutations in schizophrenia implicate synaptic networks

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

A polygenic burden of rare disruptive mutations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dynamin, a membrane-remodelling GTPase

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Structural basis of filopodia formation induced by the IRSp53/MIM homology domain of human IRSp53

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SPIN90/WISH interacts with PSD-95 and regulates dendritic spinogenesis via an N-WASP-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Channel-interacting PDZ protein, 'CIPP', interacts with proteins involved in cytoskeletal dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

WAVE signalling: from biochemistry to biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Isolation of 2000-kDa complexes of N-methyl-D-aspartate receptor and postsynaptic density 95 from mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

ProSAP/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

mDia1 and WAVE2 proteins interact directly with IRSp53 in filopodia and are involved in filopodium formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dynamin1 is a novel target for IRSp53 protein and works with mammalian enabled (Mena) protein and Eps8 to regulate filopodial dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Novel isoform of insulin receptor substrate p53/p58 is generated by alternative splicing in the CRIB/SH3-binding region

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The RAC binding domain/IRSp53-MIM homology domain of IRSp53 induces RAC-dependent membrane deformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The Cdc42 effector IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Kank regulates RhoA-dependent formation of actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Kank attenuates actin remodeling by preventing interaction between IRSp53 and Rac1

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Actin in dendritic spines: connecting dynamics to function

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

NMDA receptor and schizophrenia: a brief history

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Ultrastructure of synapses in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The postsynaptic organization of synapses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The role of the Rho GTPases in neuronal development

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of dendritic spine morphology by SPIN90, a novel Shank binding partner.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Role of an adaptor protein Lin-7B in brain development: possible involvement in autism spectrum disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Tiam1-IRSp53 complex formation directs specificity of rac-mediated actin cytoskeleton regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The postsynaptic architecture of excitatory synapses: a more quantitative view

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Evolution of synapse complexity and diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Development and Regulation of Dendritic Spine Synapses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Dendritic spines: the locus of structural and functional plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Diversity in NMDA receptor composition: many regulators, many consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Evolution of NMDA receptor cytoplasmic interaction domains: implications for organisation of synaptic signalling complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

BAIAP2 exhibits association to childhood ADHD especially predominantly inattentive subtype in Chinese Han subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Comment on Vadney and Kraushaar's "Effect of switching from Depakene to generic valproic acid on individuals with mental retardation".

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Roles of the espin actin-bundling proteins in the morphogenesis and stabilization of hair cell stereocilia revealed in CBA/CaJ congenic jerker mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

SPIN90 phosphorylation modulates spine structure and synaptic function

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Ultrastructural abnormalities in CA1 hippocampus caused by deletion of the actin regulator WAVE-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The neuronal proteins CIPP, Cypin and IRSp53 form a tripartite complex mediated by PDZ and SH3 domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Synaptopodin regulates spine plasticity: mediation by calcium stores

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Activity-dependent spine morphogenesis: a role for the actin-capping protein Eps8

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Arf6-GEF BRAG1 regulates JNK-mediated synaptic removal of GluA1-containing AMPA receptors: a new mechanism for nonsyndromic X-linked mental disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Complex formation between the postsynaptic scaffolding protein gephyrin, profilin, and Mena: a possible link to the microfilament system

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The role of PSD-95 and cypin in morphological changes in dendrites following sublethal NMDA exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

NMDA receptor-dependent synaptic translocation of insulin receptor substrate p53 via protein kinase C signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Nanoscale segregation of actin nucleation and elongation factors determines dendritic spine protrusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Memantine: a review of its use in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Spotlight on memantine in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Attention deficit hyperactivity disorder and N-methyl-D-aspartate (NMDA) dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

EPHB receptor signaling in dendritic spine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

ER to synapse trafficking of NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

New experimental treatments for core social domain in autism spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

The BAR Domain Superfamily Proteins from Subcellular Structures to Human Diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021

Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disability

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUROPHARM.2015.06.019

7 January 2021